Akebia Therapeutics | AKBA - Current Assets


Akebia Therapeutics reported $243.48M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.1B 33.9M Mar/2026
Agios Pharmaceuticals USD 834.84M 107.21M Mar/2026
Akebia Therapeutics USD 243.48M 9.47M Mar/2026
Alnylam Pharmaceuticals USD 4.22B 168.65M Mar/2026
Amgen USD 31.48B 2.42B Mar/2026
Ardelyx USD 381.87M 447K Mar/2026
Astellas Pharma JPY 1.42T 19.35B Mar/2026
AstraZeneca USD 29.61B 890M Mar/2026
Bayer EUR 35.3B 2.39B Mar/2026
BioMarin Pharmaceutical USD 4.61B 651.58M Mar/2026
Celltrion KRW 481.57B 10.97B Mar/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 1.12B 710.47M Mar/2026
Exelixis USD 1.21B 234.65M Mar/2026
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
Ironwood Pharmaceuticals USD 332.29M 58.11M Mar/2026
J&J USD 59.77B 601M Jun/2026
Kangmei Pharma CNY 6.8B 225.83M Mar/2026
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Lexicon Pharmaceuticals USD 186.03M 84.14M Mar/2026
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Moderna USD 5.77B 774M Mar/2026
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Organigram Holdings CAD 250.09M 6.46M Mar/2026
Ovoca Bio EUR 1.56M 3.39M Jun/2025
Pharma Mar EUR 273.45M 9.96M Mar/2026
Prothena USD 339.2M 24.01M Mar/2026
PTC Therapeutics USD 2.25B 19.94M Mar/2026
Qiagen NV USD 1.54B 454.82M Mar/2026
Regeneron Pharmaceuticals USD 18.21B 187.3M Mar/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 30.16B 789M Mar/2026
Sarepta Therapeutics USD 2.31B 228.06M Mar/2026
Sartorius EUR 1.64B 280M Jun/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Tectonic Therapeutic USD 239.89M 17.47M Mar/2026
Tilray USD 729.32M 28.18M Sep/2025
Vanda Pharmaceuticals USD 347.26M 20.23M Dec/2025
Zealand Pharma A/S 15.67B 950.94M Dec/2025
Zz Pientze Pharmaceu CNY 11.43B 728.95M Mar/2026